IQVIA Holdings Inc. which can be found using ticker (IQV) have now 20 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The range between the high target price and low target price is between 281 and 215 calculating the average target price we see $250.84. Given that the stocks previous close was at $213.98 this now indicates there is a potential upside of 17.2%. There is a 50 day moving average of $219.17 and the 200 moving average now moves to $210.47. The market cap for the company is 39.25B. The stock price for the company is currently 214.36 USD
The potential market cap would be $46,015,896,267 based on the market consensus.
The company has a dividend yield of 2.93%. Other points of data to note are a P/E ratio of 36.77, revenue per share of 79.12 and a 4.79% return on assets.
IQVIA Holdings Inc. is a global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. The Company operates through three segments: Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, providing outsourced clinical research and clinical trial related services. The Contract Sales & Medical Solutions segment provides health care provider, including contract sales and patient engagement services to both biopharmaceutical clients and the broader healthcare market. The Company protects individual patient privacy. The Company conducts business in more than 100 countries.
